Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype.

Wenz T, Diaz F, Spiegelman BM, Moraes CT.

Open source

DOI
10.1016/j.cmet.2008.07.006
Published
2008-09-01
Container
Cell Metab
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.cmet.2008.07.006,
  title = {Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype.},
  author = {Wenz T and  Diaz F and  Spiegelman BM and  Moraes CT.},
  year = {2008},
  journal = {Cell Metab},
  doi = {10.1016/j.cmet.2008.07.006},
  url = {https://doi.org/10.1016/j.cmet.2008.07.006}
}

RIS

TY  - JOUR
TI  - Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype.
AU  - Wenz T
AU  -  Diaz F
AU  -  Spiegelman BM
AU  -  Moraes CT.
PY  - 2008
JO  - Cell Metab
DO  - 10.1016/j.cmet.2008.07.006
UR  - https://doi.org/10.1016/j.cmet.2008.07.006
ER  - 

APA

T, W., F, D., BM, S., & CT., M. (2008). Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype.. Cell Metab. https://doi.org/10.1016/j.cmet.2008.07.006

Source records